Investor Overview

Press Releases

Date Title and Summary View
4/23/19
Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration
Additional Formats
4/4/19
Full Two-Year Data from Orthofix M6-C Artificial Cervical Disc Study Shows Significant Improvement in Pain, Function and Quality of Life Scores
Additional Formats
2/25/19
Orthofix Reports Fourth Quarter and Fiscal 2018 Financial Results, CEO Announces Plans to Retire
Additional Formats
2/7/19
Orthofix Announces FDA Approval of the M6-C Artificial Cervical Disc to Treat Patients with Cervical Disc Degeneration
Additional Formats
2/6/19
Orthofix Schedules Fourth Quarter and Fiscal 2018 Earnings Release and Conference Call for February 25, 2019
Additional Formats
2/1/19
Orthofix Acquires Options Medical
Additional Formats
1/8/19
Orthofix Announces Preliminary 2018 Fourth Quarter and Full Year Net Sales Results
Additional Formats
12/27/18
Orthofix to Present at J.P. Morgan Healthcare Conference
Additional Formats
10/29/18
Orthofix Reports Third Quarter 2018 Financial Results
Additional Formats
10/19/18
Orthofix Schedules Third Quarter 2018 Earnings Release and Conference Call for October 29, 2018
Additional Formats